• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Analysis: Drug Costs Become Bigger Issue in Cancer Care

Article

In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients.

But some top oncologists are rethinking that stance, given the soaring costs of new cancer medicines, reduced reimbursement by insurance plans and fresh research that has identified cases where cheaper generic drugs can work just as well - or better - than expensive brand-name medications.

Read the full story:

http://tinyurl.com/d2ltzp2

Source: Reuters

Related Videos
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
Eleanor Perfetto, PhD
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Ciara Zachary, PhD, MPH
Nicoletta Colombo, MD, PhD
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.